We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




ATR Prevents Division of Cells with Damaged DNA

By Biotechdaily staff writers
Posted on 14 Mar 2003
A new study describes the function of the ATR checkpoint protein in the inhibition of cell cycle progression and the prevention of breaks in double stranded DNA. More...
The study appeared in the February 19, 2002, online edition of Genes and Development.

ATR and the similar ATM protein have previously been shown to be involved in the response to DNA damage. However, earlier experiments to determine the role of ATR in preventing cells with damaged DNA from dividing have been contradictory and the precise roles of these proteins have remained obscure.

In the current study, investigators from the California Institute of Technology (Caltech, Pasadena, USA; www.caltech.edu) utilized a novel mouse model to produce cells lacking the ATR kinase. After exposure to ionizing radiation, the ATR deficient cells were found to have major defects in cell-cycle checkpoint regulation and halting of the cell cycle. These mouse cells proceeded dangerously through the cell division cycle with chromosome breaks, demonstrating a role for ATR in maintaining the integrity of DNA.

"It is a very exciting time for the DNA damage response field. Everywhere you look in these pathways, connections can be made to how cancer is normally prevented by maintaining the integrity of the genome. Subtle, yet-to-be-determined deficiencies in any of a number of these DNA damage response molecules may broadly influence cancer risk in humans,” explained first author Dr. Eric J. Brown, a researcher at Caltech.



Related Links:
California Institute of Technology

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Thyroid Test
Anti-Thyroid EIA Test
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.